Metastasis-inhibiting composition of novel methylsulfonamide derivative compound
US-2024025845-A1 · Jan 25, 2024 · US
US11795144B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11795144-B2 |
| Application number | US-201816619311-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 6, 2018 |
| Priority date | Jun 6, 2017 |
| Publication date | Oct 24, 2023 |
| Grant date | Oct 24, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention concerns a compound having the following formula (I): wherein: A is in particular —N(R′ a )—C(═O)—R, R′ a being H or a (C 1 -C 6 )alkyl group, and R being preferably a group having the following formula (II): X is in particular chosen from the group consisting of: —SO 2 —N(R′ b )—, R′ b being H or a (C 1 -C 6 )alkyl group, —N(R″ b )—SO 2 —, R″ b being H or a (C 1 -C 6 )alkyl group, —CO—NH—, and —NH—CO—, for use for the treatment of cancers, such as metastatic cancers.
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of cancer, comprising administering to a mammal in need thereof a therapeutically effective amount of a compound having the following formula (VII): wherein: p is an integer from 1 to 3 inclusive; X′ is chosen from the group consisting of: —S—, —NH—, —NR d —, —CH 2 —, —SO 2 —, and —SO—, R d being H or a (C 1 -C 6 )alkyl group; R 5 is a (C 1 -C 6 )alkyl group; and the R 4 groups, identical or different, are chosen from the (C 1 -C 6 )alkyl groups. 2. The method of claim 1 , wherein X′ is —CH 2 —or —S—. 3. The method of claim 1 , wherein the compound of formula (VII) is the following compound: 4. (Allowed) The method of claim 1 , wherein the cancer is breast cancer.
having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring · CPC title
Antineoplastic agents · CPC title
having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring · CPC title
having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring · CPC title
specific for metastasis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.